| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:A regulatory and pricing divergence in pharmaceutical markets : EU, Slovenia, U.S.
Authors:ID Heller, Thomas Allan (Author)
ID Turnšek, Ema (Author)
Files:URL https://journals.um.si/index.php/medicine/en/article/view/5975
 
.pdf 1_heller_(2).pdf (580,33 KB)
MD5: DB6D3C2C75DB13DF5BE6EC97CE28F652
 
Language:English
Work type:Unknown
Typology:1.01 - Original Scientific Article
Organization:PF - Faculty of Law
Abstract:This paper examines the chosen aspects, circumstances and frameworks in the field of pharmaceuticals. The Authors first investigate the role of the U.S., Slovenian and the EU bodies that regulate, monitor and supervise the functioning of the pharmaceutical industries. Both, the EU’s agency EMA and the U.S.’s administration FDA, try to achieve the same purpose – to establish and maintain public health and safety. With their qualifications and power, they greatly contribute to the quality of medicinal products on both markets. However, there is one big difference between them. That is the power over making the medicines available and the setting of prices. While the EMA and for example JAZMP, the Slovenian competent authority, have the control over this financial aspect, FDA does not. The paper further on examines, what are the checks and boundaries for the setting of prices and in this regard, what is regulated within the legislative framework of Slovenia, the EU and the U.S. The fact that health is a fundamental right in EU Member States, but not in the U.S., alone explains the striking divergence in the cost of drugs in the EU as compared to the U.S.
Keywords:pharmaceuticals, pharmaceutical law, setting of drug prices, medicinal products prices, comparison of the US, EU and Slovenian legal framework
Publication version:Version of Record
Publication date:01.01.2026
Year of publishing:2026
Number of pages:str. 1-41
Numbering:Vol. 19, no. 1
PID:20.500.12556/DKUM-97754 New window
UDC:339.13:61
ISSN on article:2463-7955
COBISS.SI-ID:274544387 New window
DOI:10.18690/mls.19.1.1-42.2026 New window
Publication date in DKUM:28.05.2026
Views:133
Downloads:6
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Medicine, law & society
Publisher:Pravna fakulteta, Pravna fakulteta, University of Maribor Press
ISSN:2463-7955
COBISS.SI-ID:281851136 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Title:A regulatory and pricing divergence in pharmaceutical markets: EU, Slovenia, U.S.
Abstract:Članek obravnava izbrane vidike, okoliščine in pravne ureditve na področju farmacevtskih izdelkov. Avtorja najprej preučita vlogo organov ZDA, Slovenije in EU, ki regulirajo, spremljajo in nadzirajo delovanje farmacevtske industrije. Tako agencija Unije EMA kot tudi ameriška agencija FDA si prizadevata za isti cilj – vzpostavitev in ohranitev javnega zdravja in varnosti. S svojimi kompetencami in pristojnostmi pomembno prispevata h kakovosti zdravil na obeh trgih. Med njima pa obstaja ena velika razlika. To je pristojnost za zagotavljanje dostopnosti zdravil in določanje cen. Medtem ko imajo EMA in na primer JAZMP, slovenski pristojni organ, nadzor tudi nad finančnim vidikom, FDA te pristojnosti nima. V nadaljevanju članek preučuje, kakšni so mehanizmi nadzora in omejitve za določanje cen in kako je slednje urejeno v pravnem sistemu Slovenije, EU in ZDA. Že samo dejstvo, da je zdravje temeljna pravica v državah članicah EU, v ZDA pa ne, pojasnjuje izrazito razliko v cenah zdravil v EU v primerjavi z ZDA.


Archive

Year 2015
Neznano številčenje

Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica